Insider · CIK 0001787359
Misbah Tahir
cfoofficer
Files at IGMS (IGM Biosciences, Inc.), MAZE (Maze Therapeutics, Inc.). First filing Dec 18, 2024, latest Jul 25, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $35k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | IGM Biosciences, Inc. | $11k 8,741 shares | -5% | - | |
| 37Weak | IGM Biosciences, Inc. | $1,825 1,522 shares | -1% | - | |
| 37Weak | IGM Biosciences, Inc. | $9,015 7,329 shares | -4% | - | |
| 37Weak | IGM Biosciences, Inc. | $13k 1,708 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | MAZE Maze Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +325,000 | $0.00 | $0 | 325,000 | Sep 2, 2025 |
| Jul 23, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -8,741 | $1.27 | $11k | 170,061 | Jul 25, 2025 |
| Jun 16, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -1,522 | $1.20 | $1,825 | 178,802 | Jun 20, 2025 |
| Mar 14, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -7,329 | $1.23 | $9,015 | 180,324 | Mar 18, 2025 |
| Dec 16, 2024 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -1,708 | $7.48 | $13k | 187,653 | Dec 18, 2024 |
| Nov 18, 2024 | IGMS IGM Biosciences, Inc. | AGrant or award Common Stock | +66,667 | $0.00 | $0 | 189,361 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.